You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

29 Results
Guidelines and Advice
Status: Education and Information
ID: 6-7 Version 2
Version: 2
Jun 2013
Guidelines and Advice
Status: Archived
ID: MOAC 1
Nov 2013
Guidelines and Advice
Status: Archived
ID: 12-7
Jun 2013
Guidelines and Advice
Status: Archived
ID: 12-2 Version 2.2003
Version: 2
May 2013
Guidelines and Advice
Status: Archived
ID: 2-25
Dec 2013
Guidelines and Advice
Status: Archived
ID: 5-1
Apr 2013
Guidelines and Advice
Status: Archived
ID: 6-15
Dec 2013
Guidelines and Advice
Status: Archived
ID: 6-2
Version: 2
Aug 2013
Drug
Other Name(s): Temodal®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Aug 2025
Drug
Other Name(s): Mekinist®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2025
Regimen
Cancer Type:
Central Nervous System
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    temozolomide
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
temozolomide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2025
Regimen
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    trametinib - As monotherapy in patients with BRAF V600 mutation-positive unresectable or metastatic melanoma, according to specific criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
trametinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2025

Pages